MEDICURE INC.MM

MEDICURE INC.

0.426EURD
0.0000.00%
As of today at 08:14 GMT
EUR
No trades
See on Supercharts
Next report date
April 16
Report period
Q3 2021
EPS estimate
Revenue estimate
Market capitalization
‪4.92 M‬EUR
−0.130EUR
‪−630.27 K‬EUR
‪14.83 M‬EUR
‪7.74 M‬
Beta (1Y)
0.59
Employees (FY)
25
Change (1Y)
0
Revenue / Employee (1Y)
Net income / Employee (1Y)

About MEDICURE INC


CEO
Albert D. Friesen
Headquarters
Winnipeg
Founded
1997
FIGI
BBG000F44CJ3
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. It focuses on marketing and distribution of acute care cardiovascular drug, Aggrastat; Zypitamag (pitavastatin) tablets; Sodium Nitroprusside injection. The company was founded by Albert D. Friesen on September 15, 1997 and is headquartered in Winnipeg, Canada.
Performance
‪−45%‬
‪−30%‬
‪−15%‬
‪0%‬
‪15%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−1.50 M‬‬
‪0.00‬
‪‪1.50 M‬‬
‪‪3.00 M‬‬
‪‪4.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−1.20 M‬‬
‪0.00‬
‪‪1.20 M‬‬
‪‪2.40 M‬‬
‪‪3.60 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪900.00 K‬‬
‪‪1.80 M‬‬
‪‪2.70 M‬‬
‪‪3.60 M‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−1.50 M‬‬
‪0.00‬
‪‪1.50 M‬‬
‪‪3.00 M‬‬
‪‪4.50 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Apr 16, 2025
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
‪−0.28‬
‪−0.21‬
‪−0.14‬
‪−0.07‬
‪0.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MEDICURE INC. stocks are traded under the ticker NGQ1.
NGQ1 reached its all-time high on Jan 9, 2017 with the price of 7.628 EUR, and its all-time low was 0.070 EUR and was reached on Jun 25, 2013. View more price dynamics on NGQ1 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track MEDICURE INC. financials in yearly and quarterly reports right on TradingView.
MEDICURE INC. is going to release the next earnings report on Apr 16, 2025. Keep track of upcoming events with our Earnings Calendar.
NGQ1 net income for the last quarter is ‪451.36 K‬ EUR, while the quarter before that showed ‪−830.22 K‬ EUR of net income which accounts for 154.37% change. Track more MEDICURE INC. financial stats to get the full picture.
No, NGQ1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 26, 2025, the company has 25.00 employees. See our rating of the largest employees — is MEDICURE INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDICURE INC. EBITDA is ‪−1.06 M‬ EUR, and current EBITDA margin is 6.07%. See more stats in MEDICURE INC. financial statements.
Like other stocks, NGQ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDICURE INC. stock right from TradingView charts — choose your broker and connect to your account.